Roquette Freres

Marie-helene Saniez

Laetitia Deremaux

Daniel Wils

Laëtitia Deremaux

Léon Mentink

Laetitia Guerin-Deremaux

Olaf Haeusler

Xavier Parissaux

Juergen Siepmann

Sophie Piot

Fabrizio Montecucco

Marc Salome

François Mach

Catherine Fouache

Liuming Zhou

Tom Parady

Carole Petitjean

Robert Gerhardt

Marie-Hélène Saniez

Marc Lavarde

Anne-Marie Lheritier

Chandani Perera

Dominique Baumann

Virginie Teichman-Dubois

Marie-Helene Degrave-Saniez

Marie-Helene DeGrave

Stefanie Krenzlin

Géraldine Louvet-pommier

Youness Karrout

Deremaux Laëtitia

Marie-Helene Saniez

Laëtitia Guerin-Deremaux

Marie-Hélène Degrave-Saniez

Jérôme Klaeyle

Marie-Hélène Degrave

Stéfanie Krenzlin

The present application pertains to the field of cosmetics, more specifically the field of topical care of bad odors, by the action of a bactericidal and/or bacteriostatic topical composition, and of capturing odors. The topical composition according to the invention comprises at least one cyclodextrin, a 1,4-3, 6-dianhydrohexitol and/or a 1,4-3, 6-dianhydrohexitol derivative. It can be useful for the oral sphere, but also for areas of the skin where bad odors may develop due to microbial activity, namely the underarms, crotch and feet. Preferably, the topical composition of the invention is used for treating the oral sphere, most preferably for treating halitosis.

Topical composition for treating bad body odors, in particular halitosis

The application relates to an emulsifying composition, in particular for cosmetic use, allowing an oil-in-water emulsion (O/W) to be obtained, the emulsion comprising at least one cyclodextrin and at least one O/W emulsifier of natural origin with a hydrophilic-lipophilic balance value (HLB) of more than 8. The O/W emulsifier of natural origin can be selected from alkyl polyglucosides, mixtures of at least one alkyl polyglucoside and at least one fatty alcohol, and non-ethoxylated polyol fatty esters. The application also relates to a composition of the Pickering emulsion type, in particular for cosmetic use, containing the emulsifying composition according to the invention, and to the process for preparing such a composition of the O/W Pickering emulsion type, in particular at low temperatures.

Emulsifying composition for cosmetic use for producing an O/W pickering emulsion and process for producing this emulsion

The invention relates to the non-therapeutic use of a composition comprising at least one 1,4:3,6 dianhydrohexitol for moisturising the skin, as well as to a preparation for topical use comprising at least one 1,4:3,6 dianhydrohexitol as a moisturising agent.

1,4: 3,6 dianhydrohexitols for moisturising the skin

Pharmaceutical composition and their uses are disclosed, the composition comprising at least one methyl cyclodextrin having a molar substitution (MS) degree of between 0.05 and 1.5 in the treatment and/or prevention of diseases that can be treated and/or prevented by an increase in the HDL cholesterol level.

Compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the HDL cholesterol level

The invention relates to a novel use of a pharmaceutical composition comprising at least one methyl cyclodextrin having a molar substitution (MS) degree of between 0.05 and 1.5 in the treatment and/or prevention of diseases that can be treated and/or prevented by an increase in the HDL cholesterol level. The invention also relates to the use thereof in the treatment and/or prevention of atherosclerosis or complications relating to an atheroma, and/or diseases of the central nervous system. The pharmaceutical compositions of the invention can also be used to stimulate the reduction of circulating fatty acid and triglyceride levels and to reduce or prevent atheromatous plaques.

The use of a polysaccharide in a method for improving the flora of the colon of nursing infants and/or infants, thus treating or preventing colic and enterocolitis and therefore improving and/or generally stimulating the intestinal well-being of nursing infants and/or infants. A food composition for feeding nursing infants and/or infants, including at least one polysaccharide for treating or preventing colic and enterocolitis and improving and/or stimulating the intestinal well-being of nursing infants and/or infants. The polysaccharide used is a branched maltodextrin, preferably with a molecular mass of between 400 and 4500.

Use of polysaccharides for the intestinal well-being of nursing infants and/or infants

Described is the use of soluble indigestible fiber for inducing lysis of the cell walls of eukaryotic microalgae in the lumen of the intestine of an omnivorous or carnivorous animal including an intestinal flora and also for synergistically increasing the effect of the indigestible fiber in the induction of the growth of the intestinal flora of an omnivorous or carnivorous animal. The subject matter of the invention is also the composition intended for this use and for a method of improving the health or of food supplementation.

Composition of soluble indigestible fibre and of microalgae used in the well-being field

The invention relates to the use of branched maltodextrins for inducing lysis of the cell walls of eukaryotic organisms having a polysaccharide wall in the lumen of the intestine of an omnivorous or carnivorous animal comprising an intestinal flora and also for synergistically increasing the effect of the branched maltodextrins in the induction of the growth of the intestinal flora of an omnivorous or carnivorous animal. The invention also relates to the composition intended for this use and to a method for improving health or for food supplementation.

Composition of soluble indigestible fibers and of eukaryotic organisms with a polysaccharide wall, used in the well-being field

A controlled-release oral pharmaceutical composition of at least an active agent, including: a) a lipophilic matrix consisting of lipophilic compounds and/or amphiphilic compounds; and b) an hydrophilic matrix, wherein the hydrophilic matrix includes at least an indigestible polysaccharide, the active ingredient being dispersed in the lipophilic and/or the hydrophilic matrix. The present invention also relates to a process for the preparation of such a pharmaceutical composition.

Modified starch derivative-based matrix for colon targeting

The invention relates to branched soluble glucose polymers made of starch having an amylose content of at least 30 wt %, preferably 35 wt % to 80 wt %, having a glycosidic linkage &#x3b1;-1,6 content of 7% to 10%, preferably 8% to 9%, and a MW of 50,000 to 150,000 daltons, characterized in that the polymers are resistant to pancreatic alpha amylase, expressed according to a test 'B' for a reducing sugar content of 25% to 35%, and a MW of released products of 6,000 to 12,000 daltons.

Branched soluble glucose polymers for peritoneal dialysis

A controlled release pharmaceutical dosage form for controlled release of an active ingredient, includes an active ingredient coated by a polymeric mixture of: at least a water insoluble polymer; and at least an indigestible water-soluble oligosaccharide. The use and method of making the same are also described.

Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting

The present invention relates to a composition including a mix of a polysaccharides having: 15% to 50% of glucoside linkages 1-6; a reducing sugar content of less than 20%; a polymolecularity index of less than 5; an average molecular weight with number Mn of less than 4500 g/mole and at least one active agent for treating stress, anxiety and depressive behavior, sleep disorders, obsessive-compulsive disorder, bulimia and epilepsy in humans or animals. The present invention also relates to the use of the polysaccharide for treating stress, anxiety or depressive behavior, sleep disorders, obsessive-compulsive disorder, bulimia and epilepsy in humans or animals.

Use of polysaccharides for treating stress and anxiety

The present invention describes a carbohydrate composition having a greater impact on the insulinemic response than on the glycemic response comprising a soluble dietary fiber and a glucose syrup, process to prepare it and their use in food.

Carbohydrate compositions having a greater impact on the insulinemic response than on the glycemic response, their preparation and their uses

The present invention relates to a process for crosslinking proteins, according to which the crosslinking agent is a ketose containing 3 to 5 carbon atoms and said proteins are chosen from the group comprising proteins from animal tissues, from milk or from blood, such as in particular casein, gelatin or collagen; proteins from cereals, such as in particular maize, wheat or rice proteins; protein from high-protein plants, such as in particular pea, alfalfa, lupin, barley, millet or sorghum proteins; proteins from oleaginous plants, such as in particular soybean proteins, for instance soybean cakes, rapeseed or flax proteins, for instance rapeseed cakes, sunflower, groundnut or cotton proteins; and proteins from tubers, such as in particular from potato or manioc.

Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms

The invention concerns a fiber-enriched anti-inflammatory and/or analgesic composition for the intestine, characterized in that it comprises branched maltodextrins having between 15 and 35% of glucoside bonds, 1 to 6, a reducing sugar content less than 20%, a polymolecularity index less than 5 and a number molecular weight Mn not more than 4500 g/mole.

Growing community of inventors

Morbecque, France

Daniel Wils